Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors
Giulia Bononi, Carlotta Granchi, Margherita Lapillo, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 817-836
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The Lipid Metabolic Landscape of Cancers and New Therapeutic Perspectives
Wenjun Wang, Ling Bai, Wei Li, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 83
The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation
Sara Carpi, Egeria Scoditti, Marika Massaro, et al.
Nutrients (2019) Vol. 11, Iss. 12, pp. 2855-2855
Open Access | Times Cited: 81
Endocannabinoid-Based Therapies
Daniele Piomelli, Alex Mabou Tagne
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 483-507
Open Access | Times Cited: 53
Regulation of inflammation in cancer by dietary eicosanoids
Haixia Yang, Eva Rothenberger, Tong Zhao, et al.
Pharmacology & Therapeutics (2023) Vol. 248, pp. 108455-108455
Closed Access | Times Cited: 21
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 4, pp. 1932-1958
Open Access | Times Cited: 53
Rutin as promising drug for the treatment of Parkinson’s disease: an assessment of MAO-B inhibitory potential by docking, molecular dynamics and DFT studies
Faizul Azam, Honiwa Suliman Abodabos, Ismail M. Taban, et al.
Molecular Simulation (2019) Vol. 45, Iss. 18, pp. 1563-1571
Closed Access | Times Cited: 40
Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Carlotta Granchi, Giulia Bononi, Rebecca Ferrisi, et al.
European Journal of Medicinal Chemistry (2020) Vol. 209, pp. 112857-112857
Open Access | Times Cited: 34
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors
Giulio Poli, Margherita Lapillo, Vibhu Jha, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 34, Iss. 1, pp. 589-596
Open Access | Times Cited: 34
An updated patent review of monoacylglycerol lipase (MAGL) inhibitors (2018-present)
Giulia Bononi, Giulio Poli, Flavio Rizzolio, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 31, Iss. 2, pp. 153-168
Closed Access | Times Cited: 31
Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Anca Zanfirescu, Anca Ungurianu, Dragoș Paul Mihai, et al.
Molecules (2021) Vol. 26, Iss. 18, pp. 5668-5668
Open Access | Times Cited: 27
Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives
Giulia Bononi, Miriana Di Stefano, Giulio Poli, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 10, pp. 7118-7140
Open Access | Times Cited: 19
Identification of a Possible Endocannabinoid-Mediated Mechanism of Action of Cetylated Fatty Acids
Giulia Bononi, Carlotta Granchi, Tiziano Tuccinardi, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 363-363
Open Access
Optimization of a naphthyl amide class identifies potent and selective reversible monoacylglycerol lipase (MAGL) inhibitors
Chao Song, Na Yang, Hui Deng, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118237-118237
Closed Access
Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis
Laura Micheli, Murat Bozdağ, Özlem Akgül, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 8, pp. 1923-1923
Open Access | Times Cited: 28
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors
Miriana Di Stefano, Samuele Masoni, Giulia Bononi, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115916-115916
Open Access | Times Cited: 9
Structure-Guided Discovery of cis-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors
Bernd Kuhn, Martin Ritter, Benoit Hornsperger, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Extensive Reliability Evaluation of Docking-Based Target-Fishing Strategies
Margherita Lapillo, Tiziano Tuccinardi, Adriano Martinelli, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1023-1023
Open Access | Times Cited: 24
Anticancer Potential of Small‐Molecule Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase
Shivani Jaiswal, Senthil Raja Ayyannan
ChemMedChem (2021) Vol. 16, Iss. 14, pp. 2172-2187
Closed Access | Times Cited: 20
Advanced technologies for screening and identifying covalent inhibitors
Yaolin Guo, Shuai Wen, Aiping Tong, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117833-117833
Closed Access | Times Cited: 2
Discovery of Aryl Formyl Piperidine Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase Inhibitors
Zhuoer Zhi, Wenting Zhang, Jingchun Yao, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 11, pp. 5783-5796
Closed Access | Times Cited: 18
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide
Salvatore Santamaria, Doretta Cuffaro, Elisa Nuti, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 16
The endocannabinoid system dual-target ligand N-cycloheptyl-1,2-dihydro-5-bromo-1-(4-fluorobenzyl)-6-methyl-2-oxo-pyridine-3-carboxamide improves disease severity in a mouse model of multiple sclerosis
Chiara Arena, Francesca Gado, Lorenzo Di Cesare Mannelli, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112858-112858
Open Access | Times Cited: 16
Aldose Reductase Differential Inhibitors in Green Tea
Francesco Balestri, Giulio Poli, Carlotta Pineschi, et al.
Biomolecules (2020) Vol. 10, Iss. 7, pp. 1003-1003
Open Access | Times Cited: 13
New diterpenes from Salvia pseudorosmarinus and their activity as inhibitors of monoacylglycerol lipase (MAGL)
Marinella De Leo, Conny Guillen Huallpa, Britt Alvarado, et al.
Fitoterapia (2018) Vol. 130, pp. 251-258
Open Access | Times Cited: 13
Modification on the 1,2-dihydro-2-oxo-pyridine-3-carboxamide core to obtain multi-target modulators of endocannabinoid system
Francesca Gado, Chiara Arena, Cristiana La Fauci, et al.
Bioorganic Chemistry (2019) Vol. 94, pp. 103353-103353
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top